Login

Ekso Bionics Holdings, Inc EKSO CEO Jack Peurach on 2019 Results 00:00:00

Share On Facebook Share On Twitter

Ekso Bionics Holdings, Inc EKSO CEO Jack Peurach on 2019 Results

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Amitt does not invest in Biotech / Healthcare / Greentech|Amitt Mahajan,Managing Partner, Presence Capital
00:10:00
Building Wealth and Strengthening Your Marriage: Seven Key Principles | David John Marotta, President , Marotta Wealth Management Inc.
00:00:00
Jerome D. Jabbour Chief Executive Officer, Matinas BioPharma Holdings Inc
00:10:00
Jonas Wiström on Ratos: Leadership and Strategic Direction | Jonas Wiström, CEO, Ratos.
00:10:00
"Matt Bottomley on Cannabis Market Dynamics: Analyzing iAnthus, Aphria, and MedReleaf Amid U.S.-Canada Policy Shifts"
00:10:00
Exploring Exciting Joint Ventures: A Look into Mark's Perspective at One-to-One London
00:10:00
Marinemine: Focused on Lithium and Gold Exploration in Western Australia
00:10:00
The Unspoken Reality Behind the Harvard Gates|Alex Chang,Co-Founder,Underdog Labs
00:10:00
Speech on Demand Response Services and Energy Management Initiatives by Chee Hong Tat
00:10:00
Lumentum is acquiring rival laser maker Coherent for $5.7 billion in cash and stock, with Coherent shareholders receiving $100 in cash and 1.1851 shares of Lumentum stock per share.
00:10:00
AMC CEO Adam Aron Reacts to 'Black Panther: Wakanda Forever' Box Office Success | Adam Aron, CEO, AMC Entertainment Holdings Inc.
00:10:00
"Jason Subotky on AMG Yacktman Fund and AMG Yacktman Focused Fund: Strategies for Consistent Performance Across Market Cycles"

© 2017 - Neuhu+